Exkivity (Mobocertinib) is a prescription medicine used to treat a specific type of non-small cell lung cancer (NSCLC) that has a specific genetic mutation known as epidermal growth factor receptor (EGFR) exon 20 insertion. If you have question, please e-mail Allevaire Indian Team or call Allevaire India on +91-9818274099 (Mr. Kamal Kaushal) for further details.
Exkivity (Mobocertinib) is a prescription medicine used to treat a specific type of non-small cell lung cancer (NSCLC) that has a specific genetic mutation known as epidermal growth factor receptor (EGFR) exon 20 insertion. Exkivity belongs to a class of medicines known as tyrosine kinase inhibitors (TKIs) and works by blocking the activity of certain proteins that promote the growth of cancer cells.
Exkivity (Mobocertinib) suppliers in India: Alleviare India New Delhi, INDIA.
Alleviare Life sciences Pvt. Ltd. is a consulting pharmaceutical company specializing in providing medicines under Named Patient Program/Manage Access Program. Named Patient Program/ Manage Access Program is a program designed by the government of India and governments of many countries worldwide for patients who have exhausted the treatment options available in their respective countries and are in need of the latest medicines that are available in countries of Europe and USA.
The order for Exkivity (Mobocertinib) will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.
Exkivity (Mobocertinib) is indicated for the treatment of adult patients with locally advanced or metastatic NSCLC with EGFR exon 20 insertion mutations, as detected by an FDA-approved test, who have received prior platinum-based chemotherapy.
Medicine Name: Exkivity
Generic Name: Mobocertinib
Approval Date: May 28, 2021
Company Name: Takeda Pharmaceutical Company Limited
Exkivity (Mobocertinib) is available.
Get In Touch
ALS helps patients, doctors and hospitals as a facilitator to import prescription medicine brand Exkivity (Mobocertinib) on prescription and Import License in Patient’s Name only.
For foreign countries patients, Exkivity (Mobocertinib) can be made available in Send your inquiry to find Exkivity (Mobocertinib) in China, Cambodia, Indonesia the Philippines, Singapore, Thailand, Vietnam, Hong Kong. UAE Iraq, Iran, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela. Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia. Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Algeria, Mauritius, Uganda, Zimbabwe. Australia and New Zealand.
For Exkivity (Mobocertinib) Indications And Usage, Dosage And Administration, Dosage Forms And Strengths and Drug Interactions For More Details